regulation A topic sure to generate commentary and opinion, often passionate, is social media and the pharmaceutical industry.

This is especially so in the US with calls over the years by healthcare communicators and others for clarity in the role of social media as a legitimate communication tool in a highly-regulated industry. That culminated in the public hearing by industry regulator the FDA last November into “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools,” with high expectations for draft guidelines to be published this summer.

And what about Europe? Should there be something similar happening here? How would that work in a continent that comprises over 50 different countries, different languages, different cultural and regulatory environments and legal systems? What can pharma companies do in the meantime?

These are discussion themes in the latest edition of WCG ThoughtLeaders, a podcast I host for my firm, WCG. I’ve just published the latest one on the WCG blog – a 16-minute conversation with Len Starnes, head of digital marketing and sales for the General Medicine business unit of Bayer Schering Pharma, based in Berlin.

Our wide-ranging discussion also touched on trends in Europe for pharma companies and using social media, as well as an outline of two conferences taking place in Berlin on March 29 which Bayer Schering Pharma is hosting (follow discussions with the Twitter hashtag #digpharm).

Listen to or download the podcast from the WCG blog.

10 responses to “A conversation about pharma and social media”

  1. my view..all waiting for the FDA RT @jangles: [Blog] A conversation about pharma and social media http://tinyurl.com/ydt7979 #fb #in #wcg

  2. Podcast with @jangles A conversation about pharma and social media http://tinyurl.com/ydt7979 #fb #in #wcg #digpharm #hcmktg # hcsmeu

  3. lenstarnes (Len Starnes) avatar

    Twitter Comment


    Podcast with @jangles A conversation about pharma and social media [link to post] #fb #in #wcg #digpharm #hcmktg # hcsmeu

    Posted using Chat Catcher

  4. RT @lenstarnes: Podcast with @jangles A conversation about pharma and social media http://tinyurl.com/ydt7979 #fb #in #wcg #digpharm #hc …

  5. pharmaphorum (Paul Tunnah) avatar

    Twitter Comment


    RT @lenstarnes: Podcast with @jangles A conversation about pharma and social media [link to post] #fb #in #wcg #digpharm #hcmktg

    Posted using Chat Catcher

  6. jangles (Neville Hobson) avatar

    Twitter Comment


    [Blog] A conversation about pharma and social media [link to post] #fb #in #wcg

    Posted using Chat Catcher

  7. ritters90 (Ritesh Patel) avatar

    Twitter Comment


    my view..all waiting for the FDA RT @jangles: [Blog] A conversation about pharma and social media [link to post] #fb #in #wcg

    Posted using Chat Catcher

  8. @skoko You may have seen this, but just in case, something for you: http://bit.ly/augvom

  9. topsy_top20k

    my view..all waiting for the FDA RT @jangles: [Blog] A conversation about pharma and social media http://tinyurl.com/ydt7979 #fb #in #wcg

  10. keithchilds (Keith Childs) avatar

    Twitter Comment


    @skoko You may have seen this, but just in case, something for you: [link to post]

    Posted using Chat Catcher